Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, taking place in Barcelona from 11-14 March.
Zacks Investment Research on MSN
Reasons to hold Tandem Diabetes stock in your portfolio for now
Tandem Diabetes Care, Inc.’s TNDM impressive product launches are expected to bolster growth in the upcoming quarters. A strong solvency looks encouraging. However, concerns loom over fierce ...
New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果